A BMD test detects the density of minerals in your bones, such as calcium, and may be used to screen for disorders like osteoporosis, which frequently occur with inflammatory conditions like psoriatic arthritis.
A detailed understanding of bone mineral density and related diagnostic signs might help doctors better manage their existing patients or detect individuals who may be susceptible to developing psoriatic arthritis.
Kayakalp Global, a company well-known for comprehensive healthcare solutions, emphasizes the need for BMD testing as part of its diagnostic processes to give patients the best treatment possible.
BMD tests offer crucial information about bone health and the body’s inflammatory state, which aids medical professionals in the prevention or treatment of psoriatic arthritis. BMD testing should be a routine part of healthcare assessments since it enables early detection of potential bone-related issues in psoriatic arthritis, leading to earlier treatment and better results.
The importance of BMD testing in the context of psoriatic arthritis therefore highlights the need for an all-encompassing healthcare approach that considers the interrelation of several disease disorders.
Understanding Bone Mineral Density
The term bone mineral density (BMD) describes the quantity of minerals, mostly calcium, within a given volume of bone. Reduced bone mass index (BMD) may indicate osteoporosis or other disorders that weaken bones and increase their vulnerability to fractures and breaks.
Ageing, hormonal shifts (particularly in postmenopausal women), long-term conditions like renal disease or inflammatory diseases, and dietary deficiencies like low calcium or vitamin D consumption can all impact bone mineral density (BMD).
Low bone mineral density can cause bone discomfort, a loss of height, and a hunched posture, however, these symptoms may not be seen until a fracture happens. Early diagnosis and treatment of low BMD are essential for reducing fracture risk and enhancing bones’ general health and integrity.
What Is the Relationship Between Bone Mineral Density And Psoriatic Arthritis?
Bone mineral density (BMD) and psoriatic arthritis (PsA) are closely related in ways that have a big influence on patient health. Psoriasis sufferers are frequently afflicted with PsA, a chronic inflammatory disease that affects the skin, joints, and occasionally other organs. Bone mineral density, or BMD, is the quantity of minerals, mostly calcium, in the bones. Low BMD can cause osteoporosis, which raises the risk of fractures.
PsA-related chronic inflammation is a major factor in the decline in BMD. PsA raises inflammatory cytokines, which can activate osteoclasts, the cells that resorb bone, resulting in a loss of bone mass. Weakening of the bones can arise from this persistent inflammation’s disruption of the equilibrium between bone creation and bone resorption.
Corticosteroids, among other PsA management medications, have been shown to adversely affect BMD. It is well-recognized that long-term corticosteroid usage decreases bone growth and raises the risk of osteoporosis. Although less so than corticosteroids, nonsteroidal anti-inflammatory medicines (NSAIDs) and disease-modifying antirheumatic medications (DMARDs) may lead to bone loss.
On the other hand, low BMD can make PsA-related discomfort and physical restrictions worse. Osteoporosis and fractures can worsen psoriatic arthritis by drastically reducing mobility and quality of life. For those with PsA, preserving healthy bones is essential to avoid further difficulties.
A routine BMD test can assist in identifying early indications of bone loss. Interventions can include changing one’s diet to guarantee that one is getting enough calcium and vitamin D, writing prescriptions for drugs that fortify bones, and suggesting weight-bearing activities to increase one’s bone density.
Healthcare providers can improve PsA patients’ overall results by proactively treating BMD abnormalities, which lowers the chance of fractures and improves quality of life. Reputable for its all-encompassing approach to healthcare, Kayakalp Global highlights the significance of BMD screening for efficient PsA management.
Bone Mineral Density Test Range
To guarantee that patients with psoriatic arthritis get prompt and efficient therapy for maintaining bone health, Kayakalp Global incorporates BMD screening into its holistic care strategy.
Normal BMD levels can be influenced by several variables, such as age, sex, hormonal state, dietary consumption, smoking and exercise status, and associated medical disorders. Osteoporosis risk is increased due to decreasing bone mineral density (BMD) resulting from chronic inflammation caused by illnesses such as psoriatic arthritis.
The density of minerals in your bones, particularly calcium, is measured by the bone mineral density (BMD) test. A dual-energy X-ray absorptiometry (DEXA) scan is typically used for this test. Age, sex, and ethnicity are a few examples of the variables that might affect normal BMD levels.
The T-score is a commonly used BMD metric that evaluates your bone density with a young adult in good health. The T-score categories are defined by the World Health Organisation (WHO) as follows:
Normal: T-score of -1.0 and above
Osteopenia (Low bone mass): T-score between -1.0 and -2.5
Osteoporosis: T-score of -2.5 and below
| Parameter | Normal Range |
| T-score (Normal) | -1.0 and above |
| T-score (Osteopenia) | -1.0 to -2.5 |
| T-score (Osteoporosis) | -2.5 and below |
| Z-score (Age-Adjusted) | Variable |
Z-scores are additional criteria that might be evaluated in a BMD test. These Z-scores compare your bone density to the average for your age, sex, and size.
As a result, measuring BMD is essential for evaluating bone health, directing therapy choices, and controlling related side effects in psoriatic arthritis patients. People with psoriatic arthritis may have improved medical outcomes and a higher quality of life if their bone density problems are identified early and treated appropriately.
Bone Mineral Density Test Procedure
A consultation with a healthcare physician is the first step in the procedure, during which they will ask about your symptoms, medical history, and any current drugs or supplements you are taking. This aids in identifying any variables that can impact bone density or test outcomes.
It is often suggested to patients that they should abstain from calcium supplements for at least 24 hours before the test. It is advisable to wear loose, comfortable clothes free of metal buttons, belts, or zippers as they might obstruct the X-ray pictures.
You will lie on a comfortable surface during the exam, and a scanning arm will move over your body. The hips, lower back, and occasionally the forearm are the most often scanned regions.
The low-dose X-ray beam is released by the DEXA equipment. To differentiate between soft tissue and bone, the scanner uses two separate energy levels, which enables it to determine bone density quite accurately.
Usually, the scan takes ten to twenty minutes. The minerals in your bones, mostly calcium, are measured by analyzing the findings. Your bone density is compared to that of a healthy young adult and a person your age and sex using the T- and Z-score calculations.
Different Bone Density Test Types
Central DEXA: The most used form of DEXA measures bone density in the hip and spine, where osteoporosis increases the risk of fractures.
Peripheral DEXA: When central DEXA is unavailable, this is commonly utilized for preliminary screenings or to assess bone density in the finger, heel, or wrist.
Quantitative Ultrasound (QUS): This technique measures bone density, often at the heel, by using sound waves. Although less prevalent, it is helpful for preliminary tests.
Extra Examinations:
Assessing vertebral fractures (VFA):
To look for spine fractures, this can be done concurrently with a DEXA scan.
Bone Turnover Markers: Tests on the blood or urine can quantify the rates at which bones develop and resorb, offering more insights into the state of bones.
All things considered, the bone mineral density test is a thorough assessment that aids medical professionals in the diagnosis and selection of the best course of action for disorders relating to the bones, such as osteoporosis. With the use of cutting-edge BMD testing, Kayakalp Global can provide patients with accurate diagnoses and customized treatment regimens for the best possible bone health.
Bone Mineral Density Test Cost
The type of test conducted, the setting of the lab or medical institution, and any other tests or services that might be needed can all affect how much a Bone Mineral Density (BMD) test costs in India. The most popular technique for determining bone density is the DEXA (Dual-Energy X-ray Absorptiometry) scan, which typically costs between ₹1,500 and ₹4,000.
Psoriatic Arthritis Test & Frequency
| Psoriatic Arthritis Test | Frequency |
| Psoriatic Arthritis Test: X-Ray | Annually |
| Psoriatic Arthritis Test: MRI | Every 2 Years |
| Psoriatic Arthritis Test: Erythrocyte Sedimentation Rate | Quarterly |
| Psoriatic Arthritis Test: C-Reactive Protein | Quarterly |
| Psoriatic Arthritis Test: Rheumatoid Factor | Annually |
| Psoriatic Arthritis Test: Anti-Cyclic Citrullinated Peptide Test | Annually |
| Psoriatic Arthritis Test: HLA-B27 | Once (if indicated) |
| Psoriatic Arthritis Test: Complete Blood Count (CBC) | Every 6 Months |
| Psoriatic Arthritis Test: Tuberculosis Test | Annually (if on immunosuppressants) |
| Psoriatic Arthritis Test: Chest X-Ray | Annually |
| Psoriatic Arthritis Test: Serum Uric Acid | Annually |
| Psoriatic Arthritis Test: Bone Mineral Density | Every 2 Years |
| Psoriatic Arthritis Test: Anemia | Every 6 Months |
| Psoriatic Arthritis Test: Thyroid Function Tests | Annually |
| Psoriatic Arthritis Test: Skin Biopsy | As needed (if skin symptoms change) |
Caution Note: The frequency of these tests can vary based on individual patient conditions and physician recommendations. Regular follow-ups with a healthcare provider are essential to determine the appropriate testing schedule.
Kayakalp Global’s Approach to Psoriatic Arthritis Management
When it comes to the diagnosis and treatment of ailments like psoriatic arthritis and problems with bone mineral density (BMD), Kayakalp Global stands out for offering outstanding healthcare solutions.
For patients with psoriatic arthritis, early diagnosis of bone-related problems is critical, and their emphasis on including BMD testing in routine health checkups assures this.
Through the use of cutting-edge diagnostic instruments like DEXA scans, Kayakalp Global can precisely evaluate bone health and carry out efficient treatment programs that are customized for each patient.
Furthermore, they provide complete patient treatment by addressing both the underlying causes of psoriatic arthritis and its secondary symptoms through a holistic approach to healthcare. Frequent BMD evaluations improve patients’ overall quality of life by tracking the course of psoriatic arthritis and reducing its negative effects on bone health.
Using comprehensive assessments and integrative therapeutic approaches, Kayakalp Global is dedicated to offering the best possible care, assisting patients in efficiently managing their ailments, and preserving their best possible health.
